Cargando…
Development of a Mouse-Adapted MERS Coronavirus
First identified in 2012, Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel virus that can cause acute respiratory distress syndrome (ARDS), multiorgan failure, and death, with a case fatality rate of ~35%. An animal model that supports MERS-CoV infection and causes severe lung dise...
Autores principales: | Li, Kun, McCray, Paul B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122213/ https://www.ncbi.nlm.nih.gov/pubmed/31883095 http://dx.doi.org/10.1007/978-1-0716-0211-9_13 |
Ejemplares similares
-
The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases
por: Earnest, James T., et al.
Publicado: (2017) -
Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection
por: Li, Kun, et al.
Publicado: (2020) -
Inter-individual Variation in Receptor Expression Influences MERS-CoV Infection and Immune Responses in Airway Epithelia
por: Li, Kun, et al.
Publicado: (2022) -
The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19
por: Li, Kun, et al.
Publicado: (2021) -
Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease
por: Strub, Matthew D., et al.
Publicado: (2020)